A team led by researchers from Temple University's Lewis Katz School of Medicine (LKSOM) and the University of Pittsburg has successfully eliminated HIV infection in animal models using a gene editing technique known as CRISPR.
There's no permanent cure for HIV just yet, but scientists are getting closer. A recent experiment managed to contain HIV infection in living animals.
With this new "functional cure", five HIV patients are already currently free of the virus.
After years of study, the first HIV vaccine efficacy clinical trials will begin in South Africa, with thousands of local adult volunteers.
Scientists have discovered an antibody that could neutralize 98 percent of HIV strains. The discovery could bring scientists closer to finding a way to prevent HIV transmission.
Scientists have developed a new USB tool that could perform HIV tests and provide fast and accurate reading of the amount of virus in the patient’s blood.
And such defense resembles the defense mechanism found in some African monkeys, who have SIV and are not sick of it.
A British man with HIV could possibly be cured after showing no sign of the virus following new experimental treatment.
Scientists developed new technique in measuring the adherence of a patient to their doses of antiretroviral drugs.
Scientists discovered the origin of lentiviruses – an HIV-related retrovirus – and found that earliest evidence of the virus date back 60 million years ago.
Researchers discovered a specialized killer T-cell capable of enetering hiding spots of virus during treatment and eradicating its viral pool.
A new study revealed that a new HIV drug can prevent the virus from maturing by not allowing it to be cut from its building blocks.
A new study confirmed the pptency of the new ImmTAV in combination with successful antiretroviral therapy and donated CD8+ T-cells in removing up to 85 percent of HIV-infected cells.
A new small study involving 13 HIV-positive patients revealed that a human antibody called 3BNC117 has the potential to prevent the increase of viral load in the event the patient discontinued their retroviral medications.